Clinical trial
Multicenter, Open, Prospective, Randomized Trial of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
NCT04897113 is registered in ClinicalTrials.gov with National Medical Research Center for Rehabilitation and Balneology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Open, Prospective, Randomized Trial of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
- Lead sponsor
- National Medical Research Center for Rehabilitation and Balneology
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 12, 2021
- Completion date
- December 30, 2022
- Enrollment
- 80 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, diabetes, gout, hyper beta lipoproteinemia, hyper eosinophilic syndrome, hyper ige syndrome, hyper-ldl-cholesterolemia, hyperbilirubinemia, hypercholesterolemia, nervous system diseases, neuromuscular diseases, urologic diseases